Julie du Pont focuses on mass tort product liability litigation, including pharmaceuticals, as well as complex commercial litigation. Ms. du Pont has extensive state and federal court experience representing major US and international corporations and individual clients in all phases of the litigation process, including motion practice, discovery, trial preparation and trial, and settlement and appeals. Ms. du Pont has substantial experience representing pharmaceutical companies, including Pfizer, Novartis, Bayer, Boston Scientific, Eisai and AstraZeneca, in product liability lawsuits involving both prescription drugs and medical devices.

Ms. du Pont has extensive experience in expert and science related work and a focus of her practice is developing and rebutting expert medical and scientific evidence, and litigating the admissibility of expert opinion testimony.

Prior to rejoining the firm in 2015, Ms. du Pont served as a consulting attorney to the legal department of Boehringer Ingelheim, where she oversaw litigation and worked on international initiatives related to eDiscovery, Data Privacy and Information Governance.

Ms. du Pont is committed to the firm's pro bono program and has worked with clients on a variety of matters, including orders of protection, divorce and social security benefits.

Experience

  • AstraZeneca, as national counsel, in thousands of product liability lawsuits alleging that its Proton Pump Inhibitors (PPIs) Nexium and Prilosec cause kidney injuries and other injuries. Ms. du Pont leads the expert and science teams, argues Daubert and related motions, work-ups, and takes and defendants key fact, company and expert depositions.
  • Bayer, as national counsel, in nationwide litigation involving Roundup, including serving as trial counsel and leading the coordination of expert and science defense across jurisdictions.
  • Eisai, as national counsel, in nationwide litigation involving prescription obesity medication, including coordination of both expert and science and company defense.
  • Pfizer Inc. in leading case work up for case set for trial, alleging injuries from its prescription anti-depressant medication, Zoloft.
  • Bayer Corporation in coordinating both bellwether selection and case work-ups, taking key fact deposition in first trial set case, and coordinating expert and science defense for the In re Xarelto multidistrict litigation; coordination of the expert and science defense in a case alleging injuries from its prescription oral contraceptive, Yasmin.
  • Hormone therapy (HT) products in the coordination of the expert and science teams defending claims relating to HT; presented on the "State of the Science" in federal court, assisted in the preparation of expert witnesses for several Daubert/Frye hearings; helped develop the expert defense to secure several defense verdicts, most notably in Moss, et al. v. Wyeth, Inc., et al. (D. Conn. May 2012) and Wilson v. Wyeth, et al. (E. D. Ark. Oct 2010).
  • Multiple defendants in coordinating both bellwether selection and case work-ups as well as the expert and science defense for the TRT (Testosterone Replacement Therapy) multidistrict litigation.

Recognition

The Legal 500 US
Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices—Defense (2022)
Benchmark Litigation
"Top 250 Women in Litigation" (2018)

Credentials

Education
  • JD, Northwestern University School of Law, 2001, cum laude
  • BA, Brown University, 1997, with honors
Admissions
  • New York
  • US District Court, Southern District of New York
  • US District Court, Eastern District of New York
  • US District Court, Western District of New York
Activities
  • Member, Product Liability Committee, New York City Bar
Overview

Email Disclaimer